MaaT Pharma

About:

MaaT Pharma (Microbiota as a Therapy) is a French biotech start-up.

Website: http://maatpharma.com/

Twitter/X: MaaT_Pharma

Top Investors: Bpifrance, Seventure Partners, Crédit Mutuel Innovation, Biocodex, Government of France

Description:

MaaT Pharma, a clinical stage company, has established the most complete approach to restoring patient-microbiome symbiosis to improve survival outcomes in life-threatening diseases. Committed to treating a range of cancers and Graft-versus-Host-Disease, a serious complication of allogeneic stem cell transplantation, MaaT Pharma has already achieved proof of concept in acute myeloid leukemia patients. Supporting the further expansion of our pipeline into improving outcomes of immunotherapy in solid tumors, we have built a powerful discovery and analysis platform, GutPrint®, to evaluate drug candidates, determine novel disease targets and identify biomarkers for microbiome-related conditions.